| __timestamp | Eli Lilly and Company | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 14683100000 | 1055457000 |
| Thursday, January 1, 2015 | 14921500000 | 1222277000 |
| Friday, January 1, 2016 | 15567200000 | 1382587000 |
| Sunday, January 1, 2017 | 16801100000 | 1508505000 |
| Monday, January 1, 2018 | 16811600000 | 1769378000 |
| Tuesday, January 1, 2019 | 17598300000 | 2033831000 |
| Wednesday, January 1, 2020 | 19056500000 | 2214650000 |
| Friday, January 1, 2021 | 21005600000 | 2653478000 |
| Saturday, January 1, 2022 | 21911600000 | 3118857000 |
| Sunday, January 1, 2023 | 27041900000 | 3398627000 |
| Monday, January 1, 2024 | 36624400001 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, Eli Lilly and Jazz Pharmaceuticals have shown remarkable trajectories over the past decade. From 2014 to 2023, Eli Lilly's gross profit surged by an impressive 84%, reflecting its robust market strategies and innovative product lines. In contrast, Jazz Pharmaceuticals, while smaller in scale, demonstrated a commendable growth of 222% in the same period, showcasing its agility and niche market focus.
Eli Lilly's consistent upward trend, peaking in 2023, underscores its dominance in the industry, while Jazz's rapid growth highlights its potential to disrupt larger players. This comparison not only illustrates the dynamic nature of the pharmaceutical sector but also emphasizes the importance of strategic positioning and innovation. As we look to the future, these insights provide a glimpse into the evolving landscape of healthcare and the pivotal role these companies play.
Eli Lilly and Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Eli Lilly and Company vs Johnson & Johnson: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Eli Lilly and Company or Halozyme Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Eli Lilly and Company or Jazz Pharmaceuticals plc
Who Generates Higher Gross Profit? Eli Lilly and Company or Arrowhead Pharmaceuticals, Inc.
Key Insights on Gross Profit: Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.
Gross Profit Trends Compared: Eli Lilly and Company vs Amphastar Pharmaceuticals, Inc.
Gross Profit Trends Compared: Merck & Co., Inc. vs Jazz Pharmaceuticals plc
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc and Pharming Group N.V.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Jazz Pharmaceuticals plc and Arrowhead Pharmaceuticals, Inc. Trends
Gross Profit Analysis: Comparing Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.